The evidence consistently shows that patients who receive regular monitoring of metabolic markers, titration adjustments, and nutritional guidance alongside GLP-1 therapy achieve better outcomes and tolerate treatment more durably than those who access these medications without support
However, labeling does not currently permit use of Wegovy for those with heart failure
If you have BMI 30 (or 27 with comorbidity) and need a medically proven tool, GLP-1s may offer higher effectiveness under supervision
Essen Sie also regelmig Fleisch, nehmen Sie auch den Stoff zu sich
10.1016/j.foodchem.2009.07.021 62 GomaaA
Benowitz NL, Jacob P3, Mayan H, Denaro C (1995) Sympathomimetic effects of paraxanthine and caffeine in humans